Blood Res.  2015 Dec;50(4):256-260. 10.5045/br.2015.50.4.256.

Primary bone lymphoma with multifocal osteolytic lesions: a rare case report with review of literature

• Mandal PK
• Baul S
• Dolai TK

• KMID: 2133762
• DOI: http://doi.org/10.5045/br.2015.50.4.256

Abstract

No abstract available.

MeSH Terms

Lymphoma*

Figure

• 

  Fig. 1 Digital radiograph revealing osteolytic lesions in multiple long and flat bones. (A) anteroposterior view of the skull, (B) lateral view of the skull, (C, D) right and left humeri.

• 

  Fig. 2 Bone scintigraphy with technetium-99 showing multiple bony deposits all over the body (A). Whole body fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography-computed tomography scan (B, C) revealing multiple metabolically active lytic lesions all over the skeletal system.

• 

  Fig. 3 (A) Bone marrow aspiration showing few atypical mononuclear cells (arrow) with scanty cytoplasm and vacuolations and occasional cells with prominent nucleoli (Leishman stain). (B-D) Trephine biopsy revealing a hypercellular marrow with diffuse infiltration by medium-to-large cells with scanty cytoplasm, vesicular nuclei with irregular nuclear membrane and occasional cells showing prominent nucleoli.

Reference

1. de Leval L, Braaten KM, Ancukiewicz M, et al. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol. 2003; 27:1269–1277. PMID: 12960812.

2. Coley BL, Higinbotham NL, Groesbeck HP. Primary reticulum-cell sarcoma of bone; summary of 37 cases. Radiology. 1950; 55:641–658. PMID: 14786400.

3. Gill P, Wenger DE, Inwards DJ. Primary lymphomas of bone. Clin Lymphoma Myeloma. 2005; 6:140–142. PMID: 16231853.

4. Economopoulos T, Papageorgiou S, Rontogianni D, et al. Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study. Oncologist. 2005; 10:734–738. PMID: 16249354.

5. Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007; 18:129–135. PMID: 17018705.

6. Singh T, Satheesh CT, Lakshmaiah KC, et al. Primary bone lymphoma: a report of two cases and review of the literature. J Cancer Res Ther. 2010; 6:296–298. PMID: 21119256.

7. Sato TS, Ferguson PJ, Khanna G. Primary multifocal osseous lymphoma in a child. Pediatr Radiol. 2008; 38:1338–1341. PMID: 18779959.

8. Berthet L, Cochet A, Kanoun S, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med. 2013; 54:1244–1250. PMID: 23674577.

9. Tanaka C, Nozawa K, Sano A, et al. A case of Burkitt lymphoma with multifocal bone invasion. Rinsho Byori. 2013; 61:231–236. PMID: 23785792.

10. Ahn JY, Seo YH, Park PW, et al. A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child. Ann Lab Med. 2012; 32:162–166. PMID: 22389885.

11. Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press;2008. p. 65–66.

12. Carbone A, Gloghini A, Aiello A, Testi A, Cabras A. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol. 2010; 41:621–631. PMID: 20398809.

13. Perry AM, Crockett D, Dave BJ, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol. 2013; 162:40–49. PMID: 23600716.

14. Jack AS, Barrans SL, Qian W, Stenning SP, Mead GM. Bone marrow involvement and outcome in Burkitt lymphoma and diffuse large B-cell lymphoma. Blood. 2009; 114:486–487.

15. Sirelkhatim A, Kaiserova E, Kolenova A, et al. Systemic malignancies presenting as primary osteolytic lesion. Bratisl Lek Listy. 2009; 110:630–635. PMID: 20017455.